- Home
- SIM vs OGN Comparison
SIM vs OGN Comparison
Compare SIM & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIM
- OGN
- Stock Information
- Founded
- SIM 1969
- OGN 1923
- Country
- SIM Mexico
- OGN United States
- Employees
- SIM N/A
- OGN N/A
- Industry
- SIM Steel/Iron Ore
- OGN Biotechnology: Pharmaceutical Preparations
- Sector
- SIM Industrials
- OGN Health Care
- Exchange
- SIM Nasdaq
- OGN Nasdaq
- Market Cap
- SIM 4.0B
- OGN 4.7B
- IPO Year
- SIM 1993
- OGN N/A
- Fundamental
- Price
- SIM $25.77
- OGN $15.28
- Analyst Decision
- SIM
- OGN Hold
- Analyst Count
- SIM 0
- OGN 3
- Target Price
- SIM N/A
- OGN $21.33
- AVG Volume (30 Days)
- SIM 1.1K
- OGN 3.3M
- Earning Date
- SIM 10-31-2024
- OGN 10-31-2024
- Dividend Yield
- SIM N/A
- OGN 7.33%
- EPS Growth
- SIM 159.67
- OGN 120.97
- EPS
- SIM 3.00
- OGN 5.04
- Revenue
- SIM $1,714,039,730.00
- OGN $6,409,000,000.00
- Revenue This Year
- SIM $23.83
- OGN $3.13
- Revenue Next Year
- SIM N/A
- OGN $2.18
- P/E Ratio
- SIM $8.59
- OGN $3.03
- Revenue Growth
- SIM N/A
- OGN 4.21
- 52 Week Low
- SIM $25.00
- OGN $10.84
- 52 Week High
- SIM $34.00
- OGN $23.10
- Technical
- Relative Strength Index (RSI)
- SIM 38.94
- OGN 36.03
- Support Level
- SIM $25.31
- OGN $14.39
- Resistance Level
- SIM $27.50
- OGN $15.85
- Average True Range (ATR)
- SIM 0.70
- OGN 0.51
- MACD
- SIM -0.01
- OGN -0.03
- Stochastic Oscillator
- SIM 22.10
- OGN 36.31
About SIM Grupo Simec S.A.B. de C.V.
Grupo Simec SAB de CV is a diversified manufacturer, processor, and distributor of special bar quality, or SBQ, steel, and structural steel products. The United States, Brazil, and Mexico are the biggest markets for the company. The company's SBQ products are used across a broad range of engineered end-user applications, including axles, hubs, and crankshafts for automobiles and light trucks, machine tools, and off-highway equipment. The company's structural steel products are mainly used in the non-residential construction market and other construction applications.
About OGN Organon & Co.
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.